Skip to main content
Premium Trial:

Request an Annual Quote

Jubilant Biosys Issues License to its Kinase ChemBiobases to Eisai

NEW YORK, April 29 (GenomeWeb News) - Jubilant Biosys has issued a global license to its Kinase ChemBiobases to Japan-based Eisai, the firm said yesterday. The license was issued through Patacore, Jubilant's agency in Japan.


Jubilant's Kinase ChemBiobase is a manually curated database of small molecules that focuses on kinase targets.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.